期刊文献+

尿毒症大鼠腹透模型的建立 被引量:2

下载PDF
导出
摘要 目的研制一种成功率高的尿毒症大鼠腹透模型。方法采用二次手术法切除大鼠5/6肾脏建立尿毒症模型,之后使用自制腹透管行置管术,手术切口选择上腹部,隧道出口选择后背颈部。术后第3周开始向大鼠腹腔注射腹透液,共5周。结果尿毒症模型制作过程中2只大鼠死亡,成功制作尿毒症模型34只,成功率为94.44%。腹透置管术后注射腹透液过程中,部分大鼠出现并发症,经过对症处理,最后死亡3只大鼠,成功制作尿毒症腹透大鼠模型31只,成功率为91.18%。结论切除大鼠5/6肾脏时采取电凝止血可以弥补模型制作出血多的缺憾;自制腹透管选择一次性使用静脉输液针和肝素帽,价廉实用;腹透管隧道出口置于后背颈部,既可保护管道又方便腹透给药。
出处 《江西医学院学报》 CAS 2009年第10期25-26,共2页 Acta Academiae Medicinae Jiangxi
  • 相关文献

参考文献4

二级参考文献18

  • 1魏连波,吕瑞和,马志刚,叶任高,方敬爱.人参养荣汤对慢性肾功能衰竭腹膜透析营养不良大鼠模型的治疗作用[J].中国中西医结合肾病杂志,2000,1(1):18-20. 被引量:13
  • 2刘强,马济民,候积寿.慢性肾衰动物模型的评价[J].国外医学(泌尿系统分册),1994,14(2):69-72. 被引量:12
  • 3Gretz N, Meisinger E, Stuauch M. Partial nephrectomy and chonic renal failure: ""mature"" rat model[J]. Contrib Nephrol, 1988, 60:46 - 55.
  • 4Amann K, Wiest G, Zimmer G, et al. Reduced capillary density in the myocardium of uremic rats - A stereological study[J ]. Kidney Iht, 1992,42:1079 - 1085.
  • 5Taal MM, Zandi - Nejad K, Weening B, et al. Proinflarmmatory gene expresssion and macrophage recruitment in the rat remnant kidney[ J ]. Kidney Int, 2000, 58(4): 1664 - 1676.
  • 6王海燕.肾脏病理学[M].北京:人民卫生出版社,1996:514-517
  • 7Stockeima MG, Lorenz JN, Smith FN, et al. Chronic renal failure in a mouse model of human adenin phosphoribosyltransferase deficiency [J]. Am J Physiol, 1998; 275 : 154-163
  • 8Mortier S,Faict D,Schalkwijk CG,et al.long-term exposure to new peritoneal dialysis solutions:Effects on the peritoneal membrane[J].Kidney Int,2004,66(3):1257-1265.
  • 9Zareie M,Keuning ED,ter Wee PM,et al.Improved biocompatibility of bicarbonate/lactate-buffered PDF is not related to pH[J].Nephrol Dial Transplant,2006,21 (1):208 -216.
  • 10De Vriese AS,Tilton RG,Mortier S,et al.Myofibroblast tranedifferentiation of mesothelial cells is mediated by RAGE and contributes to peritoneal fibrosis in uraemia[J].Nephrol Dial Transplant,2006,21 (9):2549-2555.

共引文献8

同被引文献22

  • 1Abelardo A, Maria YM, Rafael S, et al. Epithelial to mesenchymal transition as a triggering factor of peritoneal membrane fibrosis and anglogenesis in peritoneal dialysis patients [ J ]. Investigational Drugs, 2005,6(3) :262-268.
  • 2Zareie M, De Vriese AS, Hekking LH, et al. Immunopathological changes in a uraemie rat model for peritoneal dialysis[J]. Nephrol Dial Transplant, 2005,20 (7) : 1350-1361.
  • 3Schwenger V . GDP and AGE receptors : mechanisms of peritoneal damage[ J ]. Contrib Nephrol,2006,150 ( 3 ) :77-83.
  • 4Schwenger V, Morath C, Salava A, et al. Damage to the peritoneal membrane by glucose degradation products is mediated by the receptor for advanced glycation end-products [ J ]. J Am Soc Nephrol 2006,17(1) :199-207.
  • 5De Vriese AS, Tilton RG, Mortier S, et al. Myofibroblas transdifferentiation of mesothelial cells is mediated by RAGE and contributes to peritoneal fibros is in uraemia[ J]. Nephrol Dial Pransplant,2006, 21 (9) :2549-2555.
  • 6Comber S, Miyata T, Moulin P, et al. Vascular proliferation and enhanced expression of endothelial nitric oxide synthase in human peritoneum exposed to long-tenn peritoneal dialysis[ J ]. J Am Soc Nephrol, 2000, 11(4) : 717-728.
  • 7Kyuden Y, Ito T, Masaki T, et al. TGF-betal induced by high glucose is cont rolled by angiotensin-converting enzyme inhibitor and anglotensin II receptor blocker on cultured human peritoneal mesot helial cells[J]. Perit Dial Int, 2005,25(5) :483-491.
  • 8Hendriks PM, Ho-dac-Pannekeet MM, van Gulik TM,et al. Peritoneal sclerosis in chronic peritoneal dialysis patients:analysis of clinical presentation, risk factors, and peritoneal transport kinetics[ J]. Petit Dial Int, 1997,17(2) :136-143.
  • 9Saxena R. Pathogenesis and treatment of peritoneal membrane fail- ure [ J ]. Pediatr Nephrol,2008,23 (5) :695 - 703.
  • 10Noh H, Kim J S, Han K H, et al. Oxidative stress during perito- neal dialysis: implications in functional and structural changes in the membrane [ J ]. Kidney Int, 2006,69 ( 11 ) :2022 - 8.

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部